Evidence map›Paper›PMID 40611953›Full record

ArticleFrontiers in microbiology2025

Sylwia Jarzynka, Anna Koryszewska-Bagińska, Tomasz Nowikiewicz, Anna Szczepańska, Gabriela Olędzka, Maria Szymankiewicz

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sylwia Jarzynka *Department of Medical Biology, Medical University of Warsaw, Warsaw, Poland.
Anna Koryszewska-Bagińska *Department of Medical Biology, Medical University of Warsaw, Warsaw, Poland.
Tomasz NowikiewiczDepartment of Surgical Oncology, Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland.
Anna SzczepańskaDepartment of Microbiology, Prof. F. Łukaszczyk Oncology Centre, Bydgoszcz, Poland.
Gabriela OlędzkaDepartment of Medical Biology, Medical University of Warsaw, Warsaw, Poland.
Maria SzymankiewiczDepartment of Microbiology, Prof. F. Łukaszczyk Oncology Centre, Bydgoszcz, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Infections caused by Methods: A total of 33 methicillin-sensitive Results: Most isolates (79-100%) demonstrated a strong capacity for biofilm formation and exopolysaccharide production, confirmed by independent methods. Notably, all strains (100%) remained susceptible to ciprofloxacin at increased exposure levels. RAPD analysis revealed low genetic diversity among the isolates. Discussion: Our findings indicate that

Indexed as

adhesion genesantibiotic-resistant genesbiofilm formationbreast reconstructionexopolysaccharide productionmethicillin-sensitive Staphylococcus aureus (MSSA)screening nasal swabsvirulence factors

Identifiers

PMID40611953
PMCPMC12222067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.